Marina Gobbo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina Gobbo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Raniero Rocchi
Department of Chemical Sciences, University of Padova, Institute of Biomolecular Chemistry, C.N.R., Section of Padova, Padova, Italy
2 shared publications - Elisabetta Schievano
Department of Chemical Sciences, University of Padova, 35131 Padova, Italy
1 shared publication - Evaristo Peggion
Biopolymer Research Center, Department of Organic Chemistry, University of Padova, Via Marzolo 1, 35131 Padova, Italy
1 shared publication Laura Biondi
Department of Chemical Sciences, University of Padova, Institute of Biomolecular Chemistry, C.N.R., Section of Padova, via Marzolo 1‐3513 Padova, Italy
1 shared publicationLaura Silvestri
Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, Italy
1 shared publication- Leonardo Scaglioni
DeFENS Department of Food, Environmental and Nutritional Sciences, Via Celoria 2, I-20133 Milano, Italy
1 shared publication
Latest Publications
- 31 January 2005
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (8) , 452-462
Conformational study on glycosylated asparagine-oligopeptides by NMR spectroscopy and molecular dynamics calculations
- 31 January 2005
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (8) , 452-462
Conformational study on glycosylated asparagine-oligopeptides by NMR spectroscopy and molecular dynamics calculations
- 1 January 2004
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (1) , 3-16
Structural characterization of cyclic kallidin analogues in DMSO by nuclear magnetic resonance and molecular dynamics
The conformational properties in DMSO of two head‐to‐tail cyclic analogues of kallidin ([Lys0]‐bradykinin, KL) as well as those of the corresponding linear peptides were studied by NMR and molecular dynamics (MD) simulations. The modifications in the sequence were introduced at position 6, resulting in the four peptides, [Tyr6]‐KL (YKL), [Trp6]‐KL (WKL), cyclo‐([Tyr6]‐KL) (YCKL) and cyclo‐([Trp6]‐KL) (WCKL). The linear WKL analogue was significantly more potent than kallidin on rat duodenum preparations, whereas YKL was significantly less potent. Both cyclic peptides, YCKL and WCKL displayed similar activity, lower than that of the linear analogues and also of cyclo‐KL. The two linear analogues display high conformational flexibility in DMSO. In the predominant conformer, for both peptides, all three X‐Pro bonds adopt a trans configuration. Three out of four conformers present in YCKL and WCKL were completely assigned. The configurations at the X‐Pro bonds are the same for the two analogues. All cyclic conformers show a cis configuration in at least one X‐Pro bond and always opposite configuration for the two consecutive X‐Pro bonds. The NOE‐restrained MD calculations resulted in the detection of several elements of secondary structure in each of the conformers. Such elements are described and their possible relevance to biological activity is discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.
- 1 January 2004
- Published by Wiley in Journal of Peptide Science
- Vol. 11 (1) , 3-16
Structural characterization of cyclic kallidin analogues in DMSO by nuclear magnetic resonance and molecular dynamics
The conformational properties in DMSO of two head‐to‐tail cyclic analogues of kallidin ([Lys0]‐bradykinin, KL) as well as those of the corresponding linear peptides were studied by NMR and molecular dynamics (MD) simulations. The modifications in the sequence were introduced at position 6, resulting in the four peptides, [Tyr6]‐KL (YKL), [Trp6]‐KL (WKL), cyclo‐([Tyr6]‐KL) (YCKL) and cyclo‐([Trp6]‐KL) (WCKL). The linear WKL analogue was significantly more potent than kallidin on rat duodenum preparations, whereas YKL was significantly less potent. Both cyclic peptides, YCKL and WCKL displayed similar activity, lower than that of the linear analogues and also of cyclo‐KL. The two linear analogues display high conformational flexibility in DMSO. In the predominant conformer, for both peptides, all three X‐Pro bonds adopt a trans configuration. Three out of four conformers present in YCKL and WCKL were completely assigned. The configurations at the X‐Pro bonds are the same for the two analogues. All cyclic conformers show a cis configuration in at least one X‐Pro bond and always opposite configuration for the two consecutive X‐Pro bonds. The NOE‐restrained MD calculations resulted in the detection of several elements of secondary structure in each of the conformers. Such elements are described and their possible relevance to biological activity is discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.